• Prostatic Acid Phosphatase (PAP)
  • Adenocarcinoma of stomach (Gastric adenocarcinoma)
  • Malignant neoplasm, ovary
  • Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • F2-Isoprostanes, Urine
  • Carbamazepine Profile, Serum
  • Apolipoprotein A-I (APOA1) Gene Analysis
  • Amylase Isoenzymes
  • Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
  • Hemoglobin S, Screen, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Ehlers-Danlos Syndrome Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Ehlers-Danlos Syndrome Gene Mutation Panel, NGS
Medical Test

Clinical Utility
Access to Ehlers-Danlos Syndrome Gene Mutation Panel, NGS is restricted.